KR
64
8
EXPE
74
12
MMC
48
-3
PH
77
3
AMZN
59
4
XOM
51
-9
DFS
64
2
APA
52
2
PAYX
47
-7
KLAC
65
6
BRK.B
47
-3
AMG
38
2
DRI
48
-12
ROP
54
-6
EMC
70
12
SEE
46
2
MCD
62
10
IP
33
3
LLY
56
2
EIX
54
-4
KR
64
8
EXPE
74
12
MMC
48
-3
PH
77
3
AMZN
59
4
XOM
51
-9
DFS
64
2
APA
52
2
PAYX
47
-7
KLAC
65
6
BRK.B
47
-3
AMG
38
2
DRI
48
-12
ROP
54
-6
EMC
70
12
SEE
46
2
MCD
62
10
IP
33
3
LLY
56
2
EIX
54
-4
Financhill
Back

Astellas Pharma Quote, Financials, Valuation and Earnings

7 Powerhouse Stocks to Buy and Hold Forever

Get it now.
Sell
24

ALPMY
Astellas Pharma

Last Price:
9.55
Seasonality Move:
-0.02%

7 Day Trial

ALL ACCESS PASS

$ 7

My #1 Coin is...

All the details are on the next page.

Astellas Pharma Price Quote

$9.55

Astellas Pharma Key Stats

Sell
24
Astellas Pharma (ALPMY) is a Sell
Day range:
$9.53 - $9.59
52-week range:
$9.15 - $16.91
Dividend yield:
4.74%
P/E ratio:
23.84
P/S ratio:
1.57
P/B ratio:
1.61%
Volume:
366K
Avg. volume:
390.8K
1-year change:
-35.65%
Market cap:
$17.1B
Revenue:
$11.2B
EPS:
$-0.01

How Much Does Astellas Pharma Make?

Is Astellas Pharma Growing As A Company?

  • What Is Astellas Pharma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0%
  • What Is Astellas Pharma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.71%

Astellas Pharma Stock Price Performance

  • Did Astellas Pharma Stock Go Up Last Month?
    Astellas Pharma share price went down by -13.65% last month
  • Did ALPMY's Share Price Rise Over The Last Year?
    ALPMY share price fell by -35.65% over the past 1 year

What Is Astellas Pharma 52-Week High & Low?

Astellas Pharma Price To Free Cash Flow

Is It Risky To Buy Astellas Pharma?

  • How Much Debt Does Astellas Pharma Have?
    Total long term debt quarterly is $6.2B
  • How Much Cash Does Astellas Pharma Have?
    Cash and short term investments quarterly total is $2B
  • What Is Astellas Pharma’s Book Value Per Share?
    Book value per share is 5.95

Is Astellas Pharma Cash Flow Positive?

  • What Is ALPMY Cash Flow From Operations?
    Cash flow from operations (TTM) is $1.6B
  • What Is Astellas Pharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $3.1B
  • What Is Astellas Pharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$5.8B

Astellas Pharma Return On Invested Capital

  • Is Management Doing A Good Job?
    ALPMY return on invested capital is -0.14%
  • What Is Astellas Pharma Return On Assets?
    ROA measures how assets are converting to revenues and is -0.09%
  • What Is ALPMY Return On Equity?
    ROE is a measure of profitability and is -0.18%

Astellas Pharma Earnings Date & Stock Price

Astellas Pharma Competitors

  • Who Are Astellas Pharma's Competitors?
    Below is a list of companies who compete with Astellas Pharma or are related in some way:
    • Healios KK (HLOSF)
    • PeptiDream Inc (PPTDF)
    • Nxera Pharma Co Ltd (SOLTF)
    • Stemcell Holdings Inc (STMM)
    • Takeda Pharmaceutical Co Ltd (TAK)

Astellas Pharma Dividend Yield

Astellas Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: -71.01% 0%
Revenue: 0.17% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many ALPMY shares are owned by institutional investors?
    387.6K ALPMY shares are owned by institutional investors
  • How many ALPMY shares are owned by insiders?
    0 ALPMY shares are owned by insiders